Laboratorio Reig Jofre, S.a. · BME:RJF
Laboratorio Reig Jofre — Reig Jofre — Q1 2026 Earnings Presentation
13 slides from Laboratorio Reig Jofre's earnings presentation
Slide 1: Financial Results Q1 2026
REIG [QJ JOFRE Financial Results Q1 2026
Slide 2: Disclaimer
DISCLAIMER This presentation does not contain confidential material and may include publicly available market information that has not been independently verified by Reig Jofre. This information has been summarised and does not purport to be complete. The information contained in this presentation s
Slide 3: Key Milestones for Q1 2026
KEY MILESTONES FOR Q1 2026 Sales down 2% due to a Progress Return to upward trend temporary disruption in in biotechnology in EBITDA growth the supply chain €10 million, +1% integration Plant and biosimilar France and Belgium Progress in the start-up Launch of of new production lines injectable dalb
Slide 4: Sales by business unit
SALES By business unit SALES Q1 2026 €86 MILLION(2%) millions of euros 37% 42% 21% PHARMACEUTICAL SPECIALITY CONSUMER TECHNOLOGIES PHT PHARMACARE SPC HEALTHCARE CHC €32 MILLION / (9 %) €36 MILLION / +21% €18 MILLION / (21%) Antibiotics 11 M€ Dermatology 8 M€ ENT RJ 4 M€ (19 %) (19) % +2 % Injectable
Slide 5: Sales by business unit
SALES By business unit SALES Q1 2026 €86 MILLION(2%) millions of euros 37% 42% 21% PHARMACEUTICAL SPECIALITY CONSUMER TECHNOLOGIES PHT PHARMACARE SPC HEALTHCARE CHC €32 MILLION / (9 %) €36 MILLION / +21% €18 MILLION / (21%) • The unit is moving into the final phase of its • The Osteoarticular divisi
Slide 6: Financial Results for Q1 2026: Profit and loss account
FINANCIAL RESULTS FOR Q1 2026 Profit and loss account millions of euros • Revenue stands at €86 million, down 2% on 2025, due to the temporary disruption in Forté Pharma’s supply chain. Income Gross margin • The associated gross margin is 60% , in line with the previous year. 88 86 53 51 • Grant inc
Slide 7: Balance sheet – Assets and investments
FINANCIAL RESULTS Balance sheet – Assets and investments millions of euros ASSETS Non-current assets €73 million FIXED ASSETS Q4 2025 199 • Industrial investments are focused on completing work on the ZE2 site in Barcelona, the new antibiotic production line in Toledo and the construction of the INT
Slide 8: Balance sheet – Liabilities and debts
FINANCIAL RESULTS Balance sheet – Liabilities and debts millions of euros LIABILITIES Gross Financial Debt Net Financial Debt €117 million FINANCIAL DEBT Q4 2025 112 FINANCIAL DEBT Credit institutions +12 Other financial liabilities -7 €8 million FINANCIAL DEBT Q1 2026 117 101 102 OTHER NON- Busines
Slide 9: Alternative Performance Measures
ALTERNATIVE PERFORMANCE MEASURES Management uses certain alternative performance measures in making financial, operating and planning decisions, as well as to evaluate the performance of the Group and its subsidiaries. Management believes that these alternative performance measures provide additiona
Slide 10: Appendix I: Profit and loss account
APPENDIX I Profit and loss account millions of euros Sed ut perspiciatis INCOME STATEMENT (thousand euros) 31/03/2026 31/03/2025 V% Turnover 86.282 87.953 -2% Procurements -34.258 -33.968 -1% Changes in inventories -637 -1.161 Gross margin 51.387 52.823 -3% Work carried out for fixed assets 5.680 47
Slide 11: Appendix II: Balance sheet
APPENDIX II Balance sheet millions of euros Sed ut perspiciatis BALANCE SHEET (thousand euros) 31/03/2026 31/12/2025 BALANCE SHEET (thousand euros) 31/03/2026 31/12/2025 Goodwill 26.509 26.495 Share capital 41.110 41.110 Other intangible assets 73.395 69.581 Share Premium 19.000 19.000 Property, pla
Slide 12: Links and Additional Information
LINKS AND ADDITIONAL INFORMATION FINANCIAL AND BUSINESS INFORMATION • Results | Laboratorio Reig Jofre NOTIFICATIONS TO THE CNMV (National Securities Market Commission) • Other relevant information | Laboratorio Reig Jofre NEWSLETTER SUBSCRIPTION CENTRE • Newsletter | Laboratorio Reig Jofre LATEST N
Slide 13: Contact details
C/ Gran Capitán, 10 08970 Sant Joan Despí BARCELONA, SPAIN T. +34 93 480 67 10 www.reigjofre.com www.reigjofre.com reigjofre.com